Market Place
Sourcing Support
CollPlant Biotechnologies Unveils Inaugural ESG and Sustainability Report
29 Jul 2024 //
PR NEWSWIRE
CollPlant Bio-Prints 200cc Breast Implants, Shows Positive Preclinical Data
06 Jun 2024 //
PR NEWSWIRE
CollPlant Q1 2024 Results And Business Update
30 May 2024 //
PR NEWSWIRE
COLLPLANT Sets Q1 2024 Financial Results, Call Date
16 May 2024 //
PR NEWSWIRE
Collplant Biotechnologies Announces Date for 2023 Full Year Financial Results
26 Mar 2024 //
PR NEWSWIRE
CollPlant Issues Letter to Shareholders
15 Feb 2024 //
PR NEWSWIRE
CollPlant`s CEO to Present at the Octane Aesthetic Tech Forum Conference
08 Jan 2024 //
PR NEWSWIRE
CollPlant Begins Trial with Commercial-Size, Regenerative Breast Implants
02 Jan 2024 //
PR NEWSWIRE
Collplant Bio Announces Date For 2023 Third Quarter Financial Results
09 Nov 2023 //
PR NEWSWIRE
CollPlant Announces Patent Granted in U.S. for Photocurable Dermal Filler
01 Nov 2023 //
PR NEWSWIRE
CollPlant to Present at the H.C. Wainwright Annual Growth Conference
05 Sep 2023 //
PR NEWSWIRE
CollPlant Biotechnologies Announces Second Quarter Financial Results
24 Aug 2023 //
PR NEWSWIRE
Collplant Announces Date For 2023 Second Quarter Financial Results
09 Aug 2023 //
PR NEWSWIRE
CollPlant Achieves Milestone and To Receive $10 Million From AbbVie
26 Jun 2023 //
PR NEWSWIRE
CollPlant Biotechnologies Announces 1Q FYR For 2023
24 May 2023 //
PR NEWSWIRE
Collplant Biotechnologies Announces Date For 2022 Full Year Financial Results
14 Mar 2023 //
PR NEWSWIRE
CollPlant Issues Letter to Shareholders
24 Jan 2023 //
PR NEWSWIRE
CollPlant Announces Results in Breast Implants Porcine Study
04 Jan 2023 //
PR NEWSWIRE
CollPlant Enriches Portfolio of rhCollagen-Based Bioinks with Launch
03 Jan 2023 //
PR NEWSWIRE
CollPlant Biotechnologies Third Quarter 2022 Financial Results
01 Dec 2022 //
PRNEWSWIRE
CollPlant Expands rhCollagen-Based Bioink Platform with Launch of Collink.3D™ 90
07 Nov 2022 //
PRNEWSWIRE
CollPlant to Present at Canaccord Genuity MedTech Forum on November 17
03 Nov 2022 //
PRNEWSWIRE
CollPlant to Present at the International Conference on Biofabrication 2022
19 Sep 2022 //
PRNEWSWIRE
CollPlant Biotechnologies Provides Second Quarter 2022 Financial Results
25 Aug 2022 //
PRNEWSWIRE
CollPlant to Present and Exhibit at TERMIS Annual Conference in Toronto, Canada
05 Jul 2022 //
PRNEWSWIRE
CollPlant Biotech Provides Business Updates and Q1 2022 Financial Results
26 May 2022 //
PRNEWSWIRE
CollPlant To Present at the Aesthetics Innovation Summit 2022
11 Apr 2022 //
PRNEWSWIRE
CollPlant Bio Provides Business Updates and Fiscal Year 2021 Financial Results
24 Mar 2022 //
PRNEWSWIRE
CELLINK, CollPlant Collaborate for Production of Regenerative Breast Implants
16 Feb 2022 //
PRNEWSWIRE
CollPlant Provides Business Updates and Q3 2021 Financial Results
18 Nov 2021 //
PRNEWSWIRE
CollPlant Announces Commercial Launch of BioInk Platform with Collink.3D
15 Nov 2021 //
PRNEWSWIRE
CollPlant`s rhCollagen BioInk Used by Technion Researchers
11 Oct 2021 //
PRNEWSWIRE
CollPlant to Present at Fall Harvest-Best Ideas from the Buy-Side
30 Sep 2021 //
PRNEWSWIRE
CollPlant CEO Yehiel Tal to Discuss Emerging Uses of rhCollagen
27 Sep 2021 //
PRNEWSWIRE
MYND Life Sciences Announces Closing of $3M Convertible Debenture
09 Sep 2021 //
PRNEWSWIRE
CollPlant Biotechnologies Provides Second Quarter 2021 Financial Results
19 Aug 2021 //
PRNEWSWIRE
CollPlant to Present on the Use of Collagen BioInk as Platform for 3D printing
16 Aug 2021 //
PR NEWSWIRE
CollPlant to Supply rhCollagen STEMCELL Technologies for Use in a Broad Range
10 Dec 2020 //
PRNEWSWIRE
